Ym Biosciences is a biopharmaceutical company that develops and commercializes innovative treatments for cancer and other serious diseases. The company focuses on developing novel therapies that target the underlying causes of disease, rather than just treating the symptoms. Ym Biosciences has a portfolio of products in clinical development, including a novel immuno-oncology agent and a targeted therapy for advanced solid tumors.